AROC.NYSEArchrock, INC

Form 4: Archrock Director Hawes Receives Restricted Stock Grant

Sentiment:

Insider Transaction Report


Archrock, Inc. Director Frances Powell Hawes was granted 5,313 shares of restricted common stock under the company's 2020 Stock Incentive Plan.

Summary

  • Frances Powell Hawes, a Director of Archrock, Inc., acquired 5,313 shares of common stock.
  • The acquisition occurred on January 29, 2026, and was a grant of restricted stock.
  • The shares were granted under the Archrock, Inc. 2020 Stock Incentive Plan at a price of $0 per share.
  • The restricted stock award vests 25% on the date of grant and 25% on June 1, September 1, and December 1, 2026.
  • Following this transaction, Frances Powell Hawes beneficially owns 131,728 shares of common stock.
  • The award is subject to forfeiture or accelerated vesting under specific conditions outlined in the Award Notice and Agreement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents routine director compensation through equity, which generally aligns interests without indicating significant operational changes or financial performance.

Positives

  • The grant of restricted stock to a director aligns management and director interests with those of shareholders.
  • The transaction demonstrates continued participation of a director in the company's equity incentive plan.

Risks

  • The restricted stock award is subject to forfeiture or accelerated vesting pursuant to certain events as set out in the Award Notice and Agreement.

Future Outlook

The filing details a future vesting schedule for restricted stock, with portions vesting on June 1, September 1, and December 1, 2026, indicating a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice across industries, particularly in the energy sector, to align leadership incentives with long-term company performance and shareholder value creation. This practice is consistent with standard corporate governance frameworks.

Comparison to Industry Standards

  • Equity-based compensation for directors, such as restricted stock grants, is a widely adopted practice among publicly traded companies, including peers in the oil and gas equipment and services industry like Exterran Corporation or USA Compression Partners, LP.
  • The vesting schedule, with a portion vesting on the grant date and subsequent quarterly vesting, is a common structure designed to retain directors and incentivize sustained performance over time, similar to practices observed in companies of comparable market capitalization.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantFrances Powell Hawes granted a Power of Attorney to Stephanie C. Hildebrandt, Andrew Gratz, and William P. Bowes, Jr. to execute Forms 3, 4, and 5 on her behalf for SEC compliance.2025-04-24Streamlines SEC filing process for the reporting person, ensuring timely compliance with Section 16(a) requirements.

Related Party Transactions

  • The grant of restricted stock to Frances Powell Hawes, a director of Archrock, Inc., constitutes a transaction between the company and a related party.

Stakeholder Impact

  • Shareholders: The grant of restricted stock aligns the director's interests with shareholders by tying a portion of their compensation to the company's stock performance.
  • Employees: No direct impact on general employees is indicated by this filing.
  • Management: The Power of Attorney streamlines compliance for the director and the company's legal team.

Next Steps

  • The remaining 75% of the restricted stock award will vest in three equal installments on June 1, September 1, and December 1, 2026.

Key Dates

DateDescription
2025-04-24Effective date of the Power of Attorney granted by Frances Powell Hawes.
2026-01-29Date of restricted stock grant to Frances Powell Hawes.
2026-02-02Date the Form 4 was signed by the Attorney-in-Fact.
2026-06-01First scheduled vesting date for 25% of the restricted stock award.
2026-09-01Second scheduled vesting date for 25% of the restricted stock award.
2026-12-01Third scheduled vesting date for 25% of the restricted stock award.

Recommendation

hold

This Form 4 filing details a routine restricted stock grant to a director, which is a standard form of compensation and incentive alignment. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as it reflects no material change to the investment thesis based solely on this disclosure.

Keywords

Archrock, AROC, Form 4, Restricted Stock, Stock Grant, Insider Transaction, Director Compensation, Equity Incentive Plan, Frances Powell Hawes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.